Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes
Approximately 90% of patients with myelodysplastic syndromes (MDSs) have somatic
mutations that are known or suspected to be oncogenic in the malignant cells. The genetic …
mutations that are known or suspected to be oncogenic in the malignant cells. The genetic …
Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML
JY Zhou, S Wang, HL Yuan, YJ Xu… - American Journal of …, 2023 - Wiley Online Library
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy,
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
and allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is the only curable …
Allogeneic hematopoietic stem cell transplantation for mixed or overlap myelodysplastic/myeloproliferative disorders
A Symeonidis, S Chondropoulos, E Verigou… - Frontiers in …, 2022 - frontiersin.org
Chronic myelomonocytic leukemia (CMML) and the remaining, less frequent hybrid, mixed,
or overlap myelodysplastic syndromes/myeloproliferative neoplasms (MDSs/MPNs) are …
or overlap myelodysplastic syndromes/myeloproliferative neoplasms (MDSs/MPNs) are …
Real-world data on chronic myelomonocytic leukemia: Clinical and molecular characteristics, treatment, emerging drugs, and patient outcomes
S Castaño-Díez, M López-Guerra, C Bosch-Castañeda… - Cancers, 2022 - mdpi.com
Simple Summary Chronic myelomonocytic leukemia (CMML) is an infrequent disease with
poor prognosis and risk of progression into acute myeloid leukemia (AML). Stem cell …
poor prognosis and risk of progression into acute myeloid leukemia (AML). Stem cell …
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study
JY Zhou, YX Chen, HL Yuan, YJ Xu… - Bone Marrow …, 2024 - nature.com
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell malignancy
and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo …
and the only curable therapy is allogeneic hematopoietic stem cell transplantation (allo …
Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT
A Rovó, L Gras, B Piepenbroek… - American journal of …, 2024 - Wiley Online Library
Although CMML since long has been separated from MDS, many studies continue to
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo‐HCT) …
evaluate the outcomes of both diseases after hematopoietic cell transplantation (allo‐HCT) …
Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study
S Kurosawa, Y Shimomura, K Ishiyama… - Bone Marrow …, 2024 - nature.com
Chronic myelomonocytic leukaemia (CMML) is a haematological malignancy with a poor
prognosis. Allogeneic haematopoietic stem cell transplantation remains the only curative …
prognosis. Allogeneic haematopoietic stem cell transplantation remains the only curative …
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
F Onida, N Gagelmann, Y Chalandon, G Kobbe… - Blood, 2024 - ashpublications.org
Chronic myelomonocytic leukemia (CMML) is a heterogeneous disease presenting with
either myeloproliferative or myelodysplastic features. Allogeneic hematopoietic cell …
either myeloproliferative or myelodysplastic features. Allogeneic hematopoietic cell …
Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic over Proliferative Subtype After Allogeneic Hematopoietic Cell Transplant: A Tertiary …
Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic over Proliferative
Subtype After Allogeneic Hematopoietic Page 1 Acta Haematol , DOI: 10.1159/000539880 …
Subtype After Allogeneic Hematopoietic Page 1 Acta Haematol , DOI: 10.1159/000539880 …
Epigenetic Enzymes and Their Mutations in Cancer
A Dalmizrak, O Dalmizrak - Cancer Epigenetics, 2023 - Springer
Epigenetic mechanisms are crucial for normal development and maintenance of tissue-
specific gene expression patterns in mammals. Impaired epigenetic processes can cause …
specific gene expression patterns in mammals. Impaired epigenetic processes can cause …